Stable Factor IX Activity Following AAV-mediated Gene Transfer in Patients with Severe Hemophilia B.

被引：0
|
作者：
Nathwani, Amit [1 ,2 ]
机构：
[1] UCL, London, England
[2] Royal Free Hosp, London NW3 2QG, England
来源：
HUMAN GENE THERAPY | 2012年 / 23卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A16 / A16
页数：1
相关论文
共 50 条
  • [21] Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer (vol 119, pg 3038, 2012)
    Buchlis, G.
    Podsakoff, G. M.
    Radu, A.
    BLOOD, 2014, 123 (11) : 1768 - 1768
  • [22] Characterization of the immune response to canine factor IX following AAV-mediated intravascular gene delivery to skeletal muscle in hemophilia B dogs.
    Hui, DJ
    Mingozzi, F
    Sabatino, DE
    Mccorquodale, S
    Dillow, A
    Nichols, TC
    Arruda, VR
    High, KA
    BLOOD, 2005, 106 (11) : 377A - 377A
  • [23] AAV-mediated gene transfer in patients with severe hemophilia B: Longer follow-up and expansion of the high dose cohort
    Nathwani, A. C.
    Tuddenham, E. G. D.
    Reiss, U. M.
    Recht, M.
    Shen, Y-M
    Halka, K. G.
    Basner-Tschakarjan, E.
    Mingozzi, F.
    High, K. A.
    Gray, J. T.
    Nienhuis, A. W.
    Davidoff, A. M.
    HUMAN GENE THERAPY, 2013, 24 (12) : A25 - A26
  • [24] Sindbis-mediated gene transfer of human Factor IX towards gene therapy for hemophilia B.
    Nelson, DM
    Morgan, RA
    BLOOD, 1997, 90 (10) : 524 - 524
  • [25] A phase I trial of AAV-mediated muscle-directed gene therapy for hemophilia B.
    Manno, CS
    Herzog, RW
    Arruda, VR
    Couto, LB
    Tai, SJ
    McClelland, A
    Flake, AW
    Chew, AJ
    Fields, PA
    Armstrong, AE
    Leonard, D
    Skarsgard, ED
    Glader, BE
    Ragni, MV
    Larson, PJ
    Kay, MA
    High, KA
    BLOOD, 1999, 94 (10) : 642A - 642A
  • [26] Inhibitor formation as a function of underlying factor IX mutation in AAV-mediated muscle directed gene therapy using novel transgenic mouse models of hemophilia B.
    Armstrong, E
    Sabatino, DE
    Pleimes, M
    Schuettrumf, J
    Dobrzynski, E
    Herzog, RW
    Arruda, VR
    High, KA
    BLOOD, 2002, 100 (11) : 19A - 19A
  • [27] Australian patients in a multi-centre phase I/II trial of AAV-mediated gene transfer to the liver for severe hemophilia B
    Rasko, JEJ
    High, K
    Kay, MA
    Glader, B
    Manno, CS
    Hutchinson, S
    Dake, M
    Razavi, M
    Kaye, R
    Arruda, VR
    Herzog, R
    McClelland, A
    Pearce, G
    Rustagi, P
    Johnson, F
    Hoots, K
    Blatt, P
    Leonard, DGB
    Addya, K
    Konkle, B
    Chew, A
    Larsen, S
    Couto, L
    JOURNAL OF GENE MEDICINE, 2003, 5 (05): : S3 - S4
  • [28] AAV-mediated gene transfer of human F.IX into muscle
    Herzog, R
    Kung, J
    Hagstrom, N
    Walter, J
    Tai, S
    Fisher, K
    Wilson, J
    High, K
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2337 - P2337
  • [29] MODELING AND SIMULATION OF ERYTHROPOIETIN EXPRESSION FOLLOWING AAV-MEDIATED GENE TRANSFER
    Williams, Jason H.
    Chee, Ng
    Greig, Jenny
    Wilson, James M.
    Barrett, Jeffrey S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1090 - 1090
  • [30] Skeletal muscle-specific expression of human blood coagulation factor IX rescues factor IX deficiency mouse by AAV-mediated gene transfer
    Lihui Lai
    Li Chen
    Jianmin Wang
    Hong Zhou
    Daru Lu
    Qi Wang
    Xiaobo Gao
    Xinfang Qiu
    Jinglun Xue
    Science in China Series C: Life Sciences, 1999, 42 : 628 - 634
12345